Breaking news

Tesla Unveils Next-Generation Full Self-Driving Model With 10X AI Parameters

Advancing Autonomous Innovation

Tesla has taken another significant step toward revolutionizing autonomous driving by training a new Full Self-Driving (FSD) model that incorporates approximately 10 times more parameters than its predecessor. CEO Elon Musk recently noted on social media that the model, which includes major improvements in video compression loss and an enhanced architecture, could be ready for public release by the end of next month pending successful tests.

Enhanced Artificial Intelligence Driving the Future

The upgraded FSD model represents a substantial leap in artificial intelligence capabilities for Tesla. By expanding the parameter size, the new model can process more data, allowing the vehicle’s cameras and sensors to more accurately interpret their surroundings. This technological advancement underpins Tesla’s strategic pivot towards a future where autonomy plays a central role in driving revenue growth and maintaining a competitive edge in the electric vehicle market.

Addressing Market Pressures

Despite these promising developments, Tesla’s core automotive business continues to face challenges. Recent reports have highlighted a 16% decline in automotive revenue during the second quarter along with notable downturns in European sales. Such market pressures, compounded by reputational issues linked to Musk’s severed relationship with the White House, have led to a decline in Tesla shares by over 23% this year.

Strategic Outlook and Future Implications

While short-term obstacles persist, Tesla bulls maintain a long-term vision centered on autonomy. The introduction of innovative self-driving features and services, such as the recently launched robotaxi service in Austin, Texas, underscore Tesla’s commitment to shaping the future of transportation. As the evolving landscape of electric vehicles becomes increasingly competitive with the rise of formidable Chinese counterparts, Tesla’s investment in advanced technology remains a critical element of its strategic agenda.

EU Records €220.5 Billion Pharmaceutical Trade Surplus In 2025

The European Union secured a historic trade surplus in medicinal and pharmaceutical products in 2025, according to a report from Eurostat. Export figures reached €366.2 billion while imports totaled €145.7 billion, leading to a surplus of €220.5 billion.

Robust Growth In Exports And Imports

Exports increased by 16.0% from €315.7 billion in 2024. Imports rose by 21.0% from €120.4 billion over the same period. The data show continued expansion in trade volumes across the sector.

Leading National Performances

Ireland recorded the highest exports to non-EU countries at €93.8 billion. Germany and Belgium followed with €67.9 billion and €38.5 billion, respectively. Italy led imports at €27.5 billion, with Belgium and Germany also recording significant volumes.

Global Trade Partnerships

The United States was the largest destination for EU exports, accounting for 43.8% or €160.6 billion. Switzerland followed with 16.3% (€59.7 billion), while the United Kingdom accounted for 5.6% (€20.6 billion). On the import side, the United States supplied 41.2% of total imports (€60.1 billion), followed by Switzerland at 28.4% (€41.4 billion) and China at 9.0% (€13.1 billion).

Aretilaw firm
The Future Forbes Realty Global Properties
eCredo
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter